SOM  Biotech (SOM)  is a company established at the Barcelona Science Park with the mission to discover and develop new indications of already known drugs (repositioning) through a profitable private company committed to its shareholders, employees and society. Repositioned drug access implies discovering, pre-clinical validation, patenting and licensing already known drugs for their commercial use in unknown medical uses.  Our propietary virtual screening  platform is based on an in-silico computerized approach and the drug development is driven by a dedicated team of experts and strategy advisors.